Kardium Revenue and Competitors
Estimated Revenue & Valuation
- Kardium's estimated annual revenue is currently $90.1M per year.
- Kardium's estimated revenue per employee is $217,000
- Kardium's total funding is $325M.
Employee Data
- Kardium has 415 Employees.
- Kardium grew their employee count by 19% last year.
Kardium's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO | Reveal Email/Phone |
2 | VP, Engineering | Reveal Email/Phone |
3 | VP, Product Management | Reveal Email/Phone |
4 | VP, Regulatory Affairs & Quality Assurance | Reveal Email/Phone |
5 | VP Talent | Reveal Email/Phone |
6 | Chief Financial Officer | Reveal Email/Phone |
7 | Director, Quality Engineering | Reveal Email/Phone |
8 | Director Intellectual Property | Reveal Email/Phone |
9 | Project Manager - Clinical | Reveal Email/Phone |
10 | Senior Manager, Talent | Reveal Email/Phone |
Kardium Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $30M | 155 | -5% | $132.7M | N/A |
#2 | $10.9M | 70 | -5% | $2M | N/A |
#3 | $15.7M | 101 | 5% | N/A | N/A |
#4 | $11M | 71 | 8% | N/A | N/A |
#5 | $123.9M | 571 | -11% | $94.5M | N/A |
#6 | $22.5M | 320 | 0% | $845.8M | N/A |
#7 | $9.8M | 41 | -68% | $494.1M | N/A |
#8 | $443.8M | 821 | 11% | $371.2M | N/A |
#9 | $33.6M | 217 | 19% | N/A | N/A |
#10 | $100M | 461 | 8% | $871.5M | N/A |
What Is Kardium?
Kardium is developing a revolutionary medical device for the diagnosis and treatment of atrial fibrillation. .
keywords:N/A$325M
Total Funding
415
Number of Employees
$90.1M
Revenue (est)
19%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Kardium News
... Intershunt, Javelin, Kardium, Keystone Heart, LuxMed, Manual Surgical Sciences, Medlumics, Middlepeak, Newpace, Nuvera, Sirona Medical,...
VANCOUVER, British Columbia--(BUSINESS WIRE)--Kardium Inc. announces a successful first-in-BC investigational* clinical procedure using the...
Kardium Inc., a Vancouver, British Columbia, Canada-based developer of the Globe® Mapping and Ablation System for the treatment of atrial fibrillation, raised US $115m in financing. The round was led by Fidelity Management & Research Company LLC., with participation from funds and accounts advi ...
Kardium Inc., developer of the Globe® Mapping and Ablation System for the treatment of atrial fibrillation, has raised US $115 million in a new financing round. The round is led by Fidelity Management & Research Company LLC., together with follow-on participation by funds and accounts advised by ...
Kardium, a British Columbia-based medical device company, has secured $115 million USD from Fidelity Management and T. Rowe Price Associates. The round was led by United States-based Fidelity Management, with T. Rowe Price Associates providing follow-on investment after leading Kardium’s $40 mi ...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $108.9M | 415 | N/A | N/A |
#2 | $93.4M | 415 | -4% | N/A |
#3 | $93.4M | 415 | -1% | N/A |
#4 | $35M | 415 | 7% | N/A |
#5 | $72.8M | 416 | 2% | N/A |